Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like Merck & Co. CEO Resigns From American Manufacturing Council by Tweet August 13, 2017 Sarepta Plunged After Adverse Event Forces Trial Halt in the UK February 11, 2018 ArQule To Present Clinical Data At The 2017 ASCO Annual Meeting May 17, 2017
